Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer

Alcoholism: Clinical and Experimental Research

Volumn 20, Issue 8, 1996, Pages 1412-1417

  Del Boca, Frances K ^a   Kranzler, Henry R ^a   Brown, Joseph ^a   Korner, Patricia F ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Alcoholism Treatment; Compliance; Pharmacotherapy; Riboflavin; Ultraviolet Light

Indexed keywords

RIBOFLAVIN; TRACER;

ALCOHOLISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; ULTRAVIOLET RADIATION; URINALYSIS;

EID: 0029844984     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1996.tb01142.x     Document Type: Article

References (34)

1. Greenberg RN: Overview of patient compliance with medication dosing: A literature review. Clin Ther 6:592-599, 1984
2. Haynes RB, Taylor DW, Sackett DL: Compliance in Health Care. Baltimore, Johns Hopkins University Press, 1979
3. Babiker IE, Cooke PR, Gillett MG: How useful is riboflavin as a tracer of medication compliance? J Behav Med 12:25-38, 1989
4. Meyer RE: Some issues in the evaluation of a pharmacotherapy of alcoholism, in Naranjo CA, Sellers EM (eds): Novel Pharmacological Interventions for Alcoholism. New York, Springer-Verlag, 1992, pp 40-55
5. Cox WM, Blount JP, Crowe PA, Singh SP: Diabetic patients' alcohol use and quality of life: Relationships with prescribed treatment compliance among older males. Alcohol Clin Exp Res 20:327-331, 1996
6. Lasagna L: Commentary on "Improvement of Phase III psychotropic drug trials by intensive Phase II work". Neuropsychopharmacol 4:263-264, 1991
7. Gerson B (ed): Therapeutic drug monitoring. 1: Pharmacokinetics, technology and methodology, in Clinics in Laboratory Medicine. Philadelphia, W.B. Saunders, 1987
8. Spriet A, Simon P: Methodology of Clinical Drug Trials (translated by R. Edelstein, M. Weintraub). Basel, Karger Publishers, 1985
9. Epstein LH, Cluss PA: A behavioral medicine perspective on adherence to long-term medical regimens. J Consult Clin Psychol 50:950-971, 1982
10. Pullar T, Kumar S, Tindall H, Feely M: Time to stop counting the tablets? Clin Pharmacol Ther 46:163-168, 1989
11. Roth HP, Caron HS: Accuracy of doctor's estimates and patient's statements on adherence to a drug regimen. Clin Pharmacol Ther 23:361-370, 1978
12. Roth HP, Caron HS, Hsi BP: Measuring intake of a prescribed medication: A bottle count and a tracer technique compared. Clin Pharmacol Ther 11:228-237, 1970
13. Rudd P, Byyny RL, Zachary V, LoVerde ME, Titus C, Mitchell WD, Marshall G: The natural history of medication compliance in a drug trial: Limitations of pill counts. Clin Pharmacol Ther 46:169-176, 1989
14. Young LM, Haakenson CM, Lee KK, van Eeckout JP: Riboflavin use as a drug marker in Veterans Administration Cooperative Studies. Controlled Clin Trials 5:497-504, 1984
15. Cheung R, Dickins J, Nicholson PW, Thomas ASC, Smith HH, Larson HE, Deshmukh AA, Dobbs RJ, Dobbs SM: Compliance with anti-tuberculous therapy: A field trial of a pill-box with a concealed electronic recording device. Eur J Clin Pharmacol 35:401-407, 1988
16. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL: How often is medication taken as prescribed? A novel assessment technique. JAMA 261:3273-3277, 1989
17. Rudd P, Marshall G, Taylor CB, Agras WS: Medication monitor/ dispenser for pharmaceutical and compliance research. Clin Pharmacol Ther 29:278, 1981
18. Gordis L: General concepts for use of markers in clinical trials. Controlled Clin Trials 5:481-487, 1984
19. Kraus RP, Grof P, Arana GW, Workman RJ, Harvey KJ, Hux M: Methylene blue: A reliable and practical marker for validating compliance on the DST. J Clin Psychiatry 48:224-229, 1987
20. Hobby GL, Deuschle KW: The use of riboflavin as an indicator of isoniazid ingestion in self-medicated patients. Am Rev Respir Dis 80:415-423, 1959
21. Fuller RK, Branchey L, Brightwell DR, Derman RM, Emrick CD, Iber FL, James KE, Lacoursiere RB, Lee KK, Lowenstam I, Maany I, Neiderhiser D, Nocks JJ, Shaw S: Disulfiram treatment of alcoholism. A Veterans Administration Cooperative Study. JAMA 256:1449-1455, 1986
22. Sullivan JT, Naranjo CA, Sellers EM: Compliance among heavy alcohol users in clinical drug trials. J Subst Abuse 1:183-194, 1989
23. Veterans Administration Cooperative Study Group: Effects of treatment on morbidity in hypertension: Results in patients with diastolic blood pressure averaging 115 through 129 mm Hg. JAMA 202:1028-1034, 1976
24. Goldman AI, Holcomb R, Perry HM, Jr, Schnaper W, Fitz AE, Frohlich ED: Can dropout and other noncompliance be minimized in clinical trials? Controlled Clin Trials 3:75-89, 1982
25. Cluss PA, Epstein LH: A riboflavin method for assessment of medication compliance in children. Behav Res Methods Instrum Comput 16:444-446, 1984
26. Cluss PA, Epstein LH, Galvis SA, Fireman P, Friday G: Effect of compliance for chronic asthmatic children. J Consult Clin Psychol 52:909-910, 1984
27. Dubbert PM, King A, Rapp SR, Brief D, Martin JE, Lake M: Riboflavin as a tracer of medication compliance. J Behav Med 8:287-299, 1985
28. Fuller R, Roth H, Long S: Compliance with disulfiram treatment of alcoholism. J Chronic Dis 36:161-170, 1983
29. Kranzler HR, Burleson JA, Del Boca FK, Babor TF, Korner PF, Brown JA, Bonn MJ: Buspirone treatment of anxious alcoholics: A placebo-controlled trial. Arch Gen Psychiatry 51:720-731, 1994
30. Kranzler HR, Del Boca F, Korner P, Brown J: Adverse effects limit the usefulness of fluvoxamine for the treatment of alcoholism. J Subst Abuse Treat 10:283-287, 1993
31. Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J, Liebowitz N: Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 152:391-397, 1995
32. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B: Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Arch Gen Psychiatry 49:894-898, 1992
33. Kranzler HR, Bauer LO, Hersh D, Klinghoffer V: Carbamazepine treatment of cocaine dependence: A placebo-controlled trial. Drug Alcohol Depend 38:203-211, 1995
34. Penn ND, Peaker S, Griffiths AP, Tindall H: Use of a pharmacological indicator to monitor compliance to thyroxin. Eur J Clin Pharmacol 35:327-329, 1988